Tenaya Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · SOUTH SAN FRANCISCO
Moderate confidence (50%)
Updated Oct 20, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Tenaya Therapeutics, Inc. received a delisting notice from its exchange (Jan 26, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Tenaya Therapeutics, Inc. received a delisting notice from its exchange
Jan 26, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 28, 2026, Tenaya Therapeutics, Inc. (the Company ) received a letter from the Listing Qualifications Staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that, based upon the closing bid price of shares of the Company s common stock for the 30 consecutive business day period between December 12, 2025, through January 27, 2026, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on the Nasdaq Global Select Marke…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Biological Products, (No Diagnostic Substances)
- Subindustry
- —
- Listing
- SEC lists the ticker TNYA on Nasdaq.
- SEC CIK
- 0001858848
- Website
- —
- —
- Headquarters
- SOUTH SAN FRANCISCO
- Also known as
- —
- Legal entities
- Tenaya Therapeutics, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Tenaya Therapeutics, Inc. — Biological Products, (No Diagnostic Substances) (SIC 2836) — SOUTH SAN FRANCISCO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 28, 2026, Tenaya Therapeutics, Inc. (the Company ) received a letter from the Listing Qualifications Staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that, based upon the closing bid price of shares of the Company s common stock for the 30 consecutive business day period between December 12, 2025, through January 27, 2026, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on the Nasdaq Global Select Marke…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:11 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.